SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-088301
Filing Date
2016-03-16
Accepted
2016-03-15 21:19:10
Documents
75
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v433750_10k.htm 10-K 935289
2 EXHIBIT 21.1 v433750_ex21-1.htm EX-21.1 2197
3 EXHIBIT 31.1 v433750_ex31-1.htm EX-31.1 9959
4 EXHIBIT 32.1 v433750_ex32-1.htm EX-32.1 5172
5 GRAPHIC tpg5.jpg GRAPHIC 87677
6 GRAPHIC tpg6.jpg GRAPHIC 101635
7 GRAPHIC tpg30.jpg GRAPHIC 83508
  Complete submission text file 0001144204-16-088301.txt   7920025

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nwbo-20151231.xml EX-101.INS 1499435
9 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20151231.xsd EX-101.SCH 87959
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20151231_cal.xml EX-101.CAL 53421
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20151231_def.xml EX-101.DEF 450847
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20151231_lab.xml EX-101.LAB 555586
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20151231_pre.xml EX-101.PRE 504260
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35737 | Film No.: 161508450
SIC: 2834 Pharmaceutical Preparations